
ASX 200 ticks higher as healthcare and financials rise

The Australian sharemarket closed slightly higher on Tuesday as investors took comfort in United States President Donald Trump's recent tariff reprieves. The S&P/ASX 200 rose 13.1 points, or 0.2%, to finish at 7,761.7, extending Monday’s 1.3% gain. Optimism was supported by a rebound on Wall Street as investors cheered news that some electronics, including iPhones, would be temporarily exempt from U.S. import tariffs. President Trump added to market confidence after revealing he was considering temporary exemptions on tariffs targeting imported vehicles. The announcement sent Japanese carmakers, including Toyota, Nissan and Honda up 4.2%, 1.9%, and 3.9%, respectively. On the ASX, four of the 11 sectors finished in positive territory, with healthcare leading the advance. Notable gains came from CSL and ResMed, adding 2.6% and 0.6%, respectively. Clarity Pharmaceuticals also climbed 4.9% after reporting that the first patient had been dosed in the cohort expansion phase of its secure trial for prostate cancer. Financial stocks also rose, with Commonwealth Bank up 0.5%, National Australia Bank adding 0.7%, Westpac up 0.8%, and ANZ gaining 0.7%. However, the technology sector lagged behind as Appen lost 4.6%